GRFS
Price
$8.89
Change
+$0.12 (+1.37%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
7.33B
84 days until earnings call
Intraday BUY SELL Signals
MIRA
Price
$1.49
Change
+$0.05 (+3.47%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
60.3M
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GRFS vs MIRA

Header iconGRFS vs MIRA Comparison
Open Charts GRFS vs MIRABanner chart's image
Grifols SA
Price$8.89
Change+$0.12 (+1.37%)
Volume$2.19K
Capitalization7.33B
MIRA Pharmaceuticals
Price$1.49
Change+$0.05 (+3.47%)
Volume$8.96K
Capitalization60.3M
GRFS vs MIRA Comparison Chart in %
GRFS
Daily Signal:
Gain/Loss:
MIRA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GRFS vs. MIRA commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRFS is a Hold and MIRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (GRFS: $8.78 vs. MIRA: $1.44)
Brand notoriety: GRFS and MIRA are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GRFS: 171% vs. MIRA: 5%
Market capitalization -- GRFS: $7.33B vs. MIRA: $60.3M
GRFS [@Pharmaceuticals: Major] is valued at $7.33B. MIRA’s [@Pharmaceuticals: Major] market capitalization is $60.3M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $925.06B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $101.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRFS’s FA Score shows that 1 FA rating(s) are green whileMIRA’s FA Score has 0 green FA rating(s).

  • GRFS’s FA Score: 1 green, 4 red.
  • MIRA’s FA Score: 0 green, 5 red.
According to our system of comparison, GRFS is a better buy in the long-term than MIRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRFS’s TA Score shows that 5 TA indicator(s) are bullish while MIRA’s TA Score has 3 bullish TA indicator(s).

  • GRFS’s TA Score: 5 bullish, 3 bearish.
  • MIRA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GRFS is a better buy in the short-term than MIRA.

Price Growth

GRFS (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while MIRA (@Pharmaceuticals: Major) price change was -2.04% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.37%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was +12.76%.

Reported Earning Dates

GRFS is expected to report earnings on Feb 26, 2026.

MIRA is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-0.37% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GRFS($7.33B) has a higher market cap than MIRA($60.3M). MIRA YTD gains are higher at: 26.316 vs. GRFS (20.001). GRFS has higher annual earnings (EBITDA): 1.62B vs. MIRA (-7.87M). GRFS has more cash in the bank: 566M vs. MIRA (730K). MIRA has less debt than GRFS: MIRA (0) vs GRFS (8.82B). GRFS has higher revenues than MIRA: GRFS (7.45B) vs MIRA (0).
GRFSMIRAGRFS / MIRA
Capitalization7.33B60.3M12,154%
EBITDA1.62B-7.87M-20,557%
Gain YTD20.00126.31676%
P/E Ratio13.81N/A-
Revenue7.45B0-
Total Cash566M730K77,534%
Total Debt8.82B0-
FUNDAMENTALS RATINGS
GRFS: Fundamental Ratings
GRFS
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
83
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
46

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRFSMIRA
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
69%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
77%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GRFS
Daily Signal:
Gain/Loss:
MIRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AHKSY16.460.16
+0.97%
Asahi Kaisei Corp.
MCSHF2.45N/A
N/A
Metcash Ltd.
NMYSF0.92N/A
N/A
Namsys, Inc.
TMILF0.82N/A
N/A
TAYLOR MARITIME INVTS LTD
MMTMF0.77-0.01
-0.66%
Monument Mining Ltd.

GRFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRFS has been closely correlated with GIKLY. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GRFS jumps, then GIKLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRFS
1D Price
Change %
GRFS100%
+3.17%
GIKLY - GRFS
68%
Closely correlated
N/A
GIFOF - GRFS
37%
Loosely correlated
N/A
PFE - GRFS
28%
Poorly correlated
+1.67%
BIIB - GRFS
26%
Poorly correlated
+0.32%
SNY - GRFS
26%
Poorly correlated
-0.32%
More

MIRA and

Correlation & Price change

A.I.dvisor tells us that MIRA and AMRN have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIRA and AMRN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRA
1D Price
Change %
MIRA100%
N/A
AMRN - MIRA
20%
Poorly correlated
+4.89%
GRFS - MIRA
11%
Poorly correlated
+3.17%
RHHBF - MIRA
8%
Poorly correlated
-4.30%
JNJ - MIRA
8%
Poorly correlated
-0.04%
RHHVF - MIRA
8%
Poorly correlated
+1.94%
More